ブラジル/ロシア/インド/中国の糖尿病治療デバイス市場：セルフモニタリング血糖値計、連続血糖モニター、試験ストリップ、ランセット、インスリンポンプ、インスリンペン、インスリン注射器...市場調査レポートについてご紹介

Table of Contents

1 Introduction (Page No. – 11)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Product Description
1.3.2.1 Blood Glucose Monitoring Devices
1.3.2.1.1 Self-Monitoring Blood Glucose Meters
1.3.2.1.2 Continuous Glucose Monitors (CGM)
1.3.2.1.3 Testing Strips
1.3.2.1.4 Lancets
1.3.2.1.5 Other Blood Glucose Monitoring Devices
1.3.2.2 Insulin Delivery Devices
1.3.2.2.1 Insulin Pumps
1.3.2.2.2 Insulin Pens
1.3.2.2.3 Insulin Syringes
1.3.2.2.4 Insulin Jet Injectors
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 15)
2.1 Research Approach
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.4.1 Key Data From Secondary Sources
2.4.2 Key Data From Primary Sources
2.4.2.1 Key Industry Insights
2.5 Assumptions
2.5.1 Market Assumptions
2.5.2 Price Assumptions

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 29)
4.1 Growth Potential of this Market
4.2 BRIC Blood Glucose Monitoring Devices Market
4.3 Diabetes Care Devices Market, By Geography
4.4 China to Dominate this Market During the Forecast Period
4.5 BRIC Diabetes Care Devices Market

5 Industry Insights (Page No. – 32)
5.1 Trends
5.1.1 Growing Diabetes Care Market in India
5.1.2 Shift Towards Continuous Glucose Monitors
5.1.3 Development of Noninvasive Glucometers
5.2 Technological Advancements in Insulin Delivery Systems
5.2.1 Insulin Inhalers
5.2.2 Oral Insulin
5.2.3 Artificial Pancreas
5.2.4 Insulin Patches/Transdermal Insulin Delivery

6 Brazil: Diabetes Care Devices Market (Page No. – 37)
6.1 Introduction
6.2 Market Drivers
6.2.1 Increasing Incidence of Diabetes Especially Among Obese Population
6.2.2 Increased Collaborations and Funding to Support Diabetes Research
6.3 Market Restraints
6.3.1 Lack of Awareness
6.3.2 Geographical Limitations
6.4 Market Opportunities
6.4.1 Favorable Government Policies
6.5 Market Challenges
6.5.1 Stringent Regulations and Registration Process
6.6 Market Size
6.7 Market Share

7 Russia: Diabetes Care Devices Market (Page No. – 44)
7.1 Introduction
7.2 Market Drivers
7.2.1 Growth in Aging Population
7.2.2 Large Urban Population and Rising Obesity
7.2.3 Growing Focus of Market Players Towards Russia
7.3 Market Restraints
7.3.1 High Cost of Diabetes Care Devices
7.3.2 Disparity in Reimbursement
7.3.3 Large Pool of Undiagnosed Patients
7.4 Market Opportunities
7.4.1 Growing Awareness About Diabetes
7.5 Market Challenges
7.5.1 Shortage of Healthcare Professionals in Diabetes Management
7.6 Market Size
7.7 Market Share

8 India: Diabetes Care Devices Market (Page No. – 52)
8.1 Introduction
8.2 Market Drivers
8.2.1 Increasing Diabetic Population
8.2.2 Life Style Changes Driving Prevalence of Diabetes Among Urban Population
8.2.3 Growing Research on Diabetes and Its Management
8.3 Market Restraints
8.3.1 High Cost of Treatment and Devices
8.3.2 Emerging Alternative Therapies
8.3.3 Lack of Awareness
8.4 Market Opportunities
8.4.1 Huge Untapped Market Potential for Diabetes Care Devices
8.5 Market Challenges
8.5.1 Pricing Pressure Faced By Global Players
8.6 Market Size
8.7 Market Share

9 China: Diabetes Care Devices Market (Page No. – 61)
9.1 Introduction
9.2 Market Drivers
9.2.1 Rising Diabetic Population
9.2.2 Increasing Number of International Research Collaborations
9.2.3 Expansion of Global Players and Growing Government Initiatives
9.3 Market Restraints
9.3.1 High Cost of Treatment and Devices
9.3.2 Traditional Chinese Medicine as an Alternative
9.3.3 Low Reimbursement for Diabetes Care Devices
9.4 Market Opportunities
9.4.1 Improved Primary Care Structure
9.5 Market Challenges
9.5.1 Nonadherence to International Standards and Gmps By Local Manufacturers
9.5.2 Regulatory Scenario
9.6 Market Size
9.7 Market Share

10 Competitive Landscape (Page No. – 71)
10.1 Competitive Situation and Trends
10.1.1 Expansions
10.1.2 Agreements, Partnerships, and Collaborations
10.1.3 New Product Launches

11 Company Profiles (Page No. – 75)
(Business Overview, Products & Services, Key Insights, Recent Developments, MnM View)*
11.1 Roche Diagnostics Limited
11.2 Johnson & Johnson
11.3 Abbott Laboratories
11.4 Bayer AG
11.5 Medtronic PLC
11.6 Becton, Dickinson and Company
11.7 Ypsomed AG
11.8 Novo Nordisk A/S
11.9 Arkray, Inc.
11.10 Sanofi
11.11 Acon Laboratories, Inc.
11.12 Terumo Corporation
11.13 Dexcom, Inc.

*Details on Business Overview, Products & Services, Key Insights, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 101)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Available Customizations
12.4 Introducing RT: Real Time Market Intelligence
12.5 Related Reports